Sangamo Therapeutics (SGMO)

$0.11 -0.07 (-37.27%)
Market Cap 73.58M
Revenue (ttm) 39.55M
Net Income (ttm) -122.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -310.82%
Debt to Equity Ratio 0.00
Volume 44,541,699
Avg Vol 10,731,998
Day's Range N/A - N/A
Shares Out 414.28M
Stochastic %K 4%
Beta 1.04
Analysts Sell
Price Target $3.75

Company Profile

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; small fiber neuropathy for chronic neuropathic pain, and prion disease; Phase 1/2 clinical trial to evaluate the...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 970 6000
Address:
501 Canal Blvd, Richmond, United States
Wischmop
Wischmop Sep. 5 at 10:17 PM
$SGMO
0 · Reply
ican
ican Sep. 5 at 3:16 PM
$SGMO I am hoping for a sensible vc group could buy out the remaining assets , use the NOL's and the rest us shareholders be a part of that , and we get a distribution from the previously sold assets . I think that would be a win for us existing shareholders. What are your thoughts out there for the rest of us remaining share holders?
1 · Reply
Chipoo
Chipoo Sep. 5 at 2:16 PM
$SGMO One positive thought, is someone maybe making a bid for all remaining assets, including the Fabry CVR. Only positive if the price is right though.
0 · Reply
Wischmop
Wischmop Sep. 5 at 7:12 AM
$SGMO Since the bankruptcy estate is massively solvent, a "NewCo" model—which would dilute common shareholders and siphon off remaining cash—is legally impossible under the Absolute Priority Rule. Once all creditors have been paid in full (100%), the law dictates that any remaining surplus belongs to the shareholders. The risk you mentioned would only materialize if, for example, Eli Lilly or PTC were to pull out at the last minute—perhaps due to unmet closing conditions or newly discovered flaws in the data. In that scenario, creditors would take control, wipe out the shareholders, and form their own NewCo.
1 · Reply
Wischmop
Wischmop Sep. 5 at 7:08 AM
$SGMO
0 · Reply
Wischmop
Wischmop Sep. 4 at 8:56 PM
$SGMO @Patrick2343 @ican @Chipoo We know the official numbers from the July MOR: $78.1 million in prepetition unsecured legacy claims, plus the DIP drawdown. Any dollar amount not officially listed there or recognized by the court effectively ceases to exist in the eyes of the That $78.1 million represents the absolute ceiling. While it is not guaranteed, there is a strong possibility that through settlements, statutory caps, and the elimination of invalid claims, this figure could potentially be negotiated down to roughly $20 to $25 million—which is exactly what the current base-case models project. Aside from that, you are familiar with the waterfall models—which, in my view, provide a very precise breakdown ranging from worst-case to base-case and best-case scenarios. These have been shared here on the forum and are readily accessible on X. I can’t imagine retail investors have ever had this level of forensic transparency when buying a regular stock in the past...
2 · Reply
Wischmop
Wischmop Sep. 4 at 3:14 PM
$SGMO There is one caveat, though: you have to be able to wait. The share price won't reflect this—or at best, only with a huge discount, just like right now... Sensible next steps: 1. Plan Confirmation: The insolvency court confirms the restructuring and distribution plan. 2. Cancellation of Old Shares: The old Sangamo shares are removed from your account on the effective date. 3. Direct Credit: Instead of volatile stock market trading, settlement is handled directly through the clearing system (DTC). You receive the court-determined cash distribution directly credited to your settlement account—plus any CVR certificates for later milestones. You're trading liquidity for returns. Those with patience will pocket the difference that the market takes from impatient sellers. My advice: forget about the share price!
2 · Reply
lpalmieri
lpalmieri Sep. 4 at 3:00 PM
$SGMO remember that every $41.5M is a $0.10 more for equity holders
0 · Reply
Wischmop
Wischmop Sep. 4 at 2:55 PM
$SGMO
0 · Reply
Chipoo
Chipoo Sep. 4 at 10:28 AM
$SGMO I'm surprised an auction date has not been announced. The Equity committee only wanted to extend by 2 weeks and it appears they will get that and maybe even longer.
1 · Reply
Latest News on SGMO
No data available.
Wischmop
Wischmop Sep. 5 at 10:17 PM
$SGMO
0 · Reply
ican
ican Sep. 5 at 3:16 PM
$SGMO I am hoping for a sensible vc group could buy out the remaining assets , use the NOL's and the rest us shareholders be a part of that , and we get a distribution from the previously sold assets . I think that would be a win for us existing shareholders. What are your thoughts out there for the rest of us remaining share holders?
1 · Reply
Chipoo
Chipoo Sep. 5 at 2:16 PM
$SGMO One positive thought, is someone maybe making a bid for all remaining assets, including the Fabry CVR. Only positive if the price is right though.
0 · Reply
Wischmop
Wischmop Sep. 5 at 7:12 AM
$SGMO Since the bankruptcy estate is massively solvent, a "NewCo" model—which would dilute common shareholders and siphon off remaining cash—is legally impossible under the Absolute Priority Rule. Once all creditors have been paid in full (100%), the law dictates that any remaining surplus belongs to the shareholders. The risk you mentioned would only materialize if, for example, Eli Lilly or PTC were to pull out at the last minute—perhaps due to unmet closing conditions or newly discovered flaws in the data. In that scenario, creditors would take control, wipe out the shareholders, and form their own NewCo.
1 · Reply
Wischmop
Wischmop Sep. 5 at 7:08 AM
$SGMO
0 · Reply
Wischmop
Wischmop Sep. 4 at 8:56 PM
$SGMO @Patrick2343 @ican @Chipoo We know the official numbers from the July MOR: $78.1 million in prepetition unsecured legacy claims, plus the DIP drawdown. Any dollar amount not officially listed there or recognized by the court effectively ceases to exist in the eyes of the That $78.1 million represents the absolute ceiling. While it is not guaranteed, there is a strong possibility that through settlements, statutory caps, and the elimination of invalid claims, this figure could potentially be negotiated down to roughly $20 to $25 million—which is exactly what the current base-case models project. Aside from that, you are familiar with the waterfall models—which, in my view, provide a very precise breakdown ranging from worst-case to base-case and best-case scenarios. These have been shared here on the forum and are readily accessible on X. I can’t imagine retail investors have ever had this level of forensic transparency when buying a regular stock in the past...
2 · Reply
Wischmop
Wischmop Sep. 4 at 3:14 PM
$SGMO There is one caveat, though: you have to be able to wait. The share price won't reflect this—or at best, only with a huge discount, just like right now... Sensible next steps: 1. Plan Confirmation: The insolvency court confirms the restructuring and distribution plan. 2. Cancellation of Old Shares: The old Sangamo shares are removed from your account on the effective date. 3. Direct Credit: Instead of volatile stock market trading, settlement is handled directly through the clearing system (DTC). You receive the court-determined cash distribution directly credited to your settlement account—plus any CVR certificates for later milestones. You're trading liquidity for returns. Those with patience will pocket the difference that the market takes from impatient sellers. My advice: forget about the share price!
2 · Reply
lpalmieri
lpalmieri Sep. 4 at 3:00 PM
$SGMO remember that every $41.5M is a $0.10 more for equity holders
0 · Reply
Wischmop
Wischmop Sep. 4 at 2:55 PM
$SGMO
0 · Reply
Chipoo
Chipoo Sep. 4 at 10:28 AM
$SGMO I'm surprised an auction date has not been announced. The Equity committee only wanted to extend by 2 weeks and it appears they will get that and maybe even longer.
1 · Reply
Jeffkad
Jeffkad Sep. 3 at 3:59 PM
$SGMO actually still feeling very good about this. Risk/reward is decidedly skewed to the positive, and don’t see a lot of downside.
0 · Reply
Jeffkad
Jeffkad Sep. 3 at 2:11 PM
$SGMO @lpalmieri @greko50 so are you guys in agreement with this latest waterfall?
1 · Reply
greko50
greko50 Sep. 3 at 8:14 AM
$SGMO Jul MOR finally out yesterday. Here is my updated Equity Waterfall......
4 · Reply
TGTT888
TGTT888 Sep. 3 at 6:35 AM
$SGMO As I understand it, the costs amount to approximately $60 million: $20 million for DIP financing, and $10 million in legal and procedural costs. $40 million represents legacy liabilities; roughly $40 million of the total is likely to be eliminated, as these are internal items.
0 · Reply
lpalmieri
lpalmieri Sep. 2 at 9:32 PM
$SGMO Docket 427 - MOR period covering from the 1st to the 31st July. (continue in the comments)
2 · Reply
Chipoo
Chipoo Sep. 2 at 8:19 PM
$SGMO The MOR is published. Have at it accounting Pro's, I do not understand. https://www.veritaglobal.net/sangamotherapeutics/document/2610989260902000000000008
2 · Reply
MAKO1992
MAKO1992 Sep. 2 at 2:24 PM
$SGMO is there anything new? they have a court hearing today on Sept 2 still?
3 · Reply
JimiJoJeeter
JimiJoJeeter Sep. 1 at 6:43 PM
$SGMO https://phys.org/news/2026-08-gene-tool-crispr-body.html
1 · Reply
tcamp12
tcamp12 Sep. 1 at 12:49 PM
$SGMO Totally confused . in this for 5yrs had some quick gains and most of all losses and looking for exit point. Set for .30 but no idea what and when we expect the final walk away price. I literally have no idea how or when to walk if not already which I obviously did not. What is left? What are we waiting for? What realistically are the possibilities?
2 · Reply
JimiJoJeeter
JimiJoJeeter Aug. 31 at 8:35 PM
$SGMO
0 · Reply
Plyaden
Plyaden Aug. 31 at 6:20 PM
$SGMO it's like they planned to transfer this assets to lilly and work for them after everything is done.. contract with the devil. Shareholders are the biggest losers of this situation.. is this legal?
2 · Reply
RGBP_No_Bid
RGBP_No_Bid Aug. 31 at 3:35 PM
$SGMO Gee, again with the imaginary short covering? The price for investing via fiction is losses. "Price since post -69.06%"
0 · Reply